stockportfolio.pro
Stocks / INSP vs IRMD
INSP vs IRMD
Inspire Medical Systems, Inc. and IRADIMED CORPORATION side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Inspire Medical Systems, Inc. (INSP) | IRADIMED CORPORATION (IRMD) | |
|---|---|---|
| Market cap | $1.2B | $1.2B |
| Revenue (latest FY) | $911.98M | $83.81M |
| Net income (latest FY) | $145.42M | $22.48M |
| Revenue growth (5y CAGR) | 51.2% | 21.5% |
| Net margin | 15.9% | 26.8% |
| Return on equity | 18.6% | 23.8% |
| P/E ratio | 9.6 | 52.3 |
| Dividend yield | — | 0.8% |
| Profitable years (of last 10) | 2 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open INSP — free Open IRMD — freeFrequently asked questions
Which is bigger, INSP or IRMD?
IRADIMED CORPORATION is larger by market capitalization — $1.2B versus $1.2B.
Which grows faster, INSP or IRMD?
Over the last five fiscal years, Inspire Medical Systems, Inc. grew revenue faster — 51.2%/yr versus 21.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.